Home › Asset managers › Compare 2025-2026 › American Century vs John Hancock
American Century 2025-2026 · John Hancock 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 21,828 | 19,637 | 1,047 | 1,144 | 94.9% | 93.3% |
| Board proposals | 17,883 | 16,065 | 1,012 | 806 | 94.1% | 92.7% |
| E&S shareholder proposals | 155 | 85 | 6 | 64 | 93.4% | 85.1% |
| Other items | 3,790 | 3,487 | 29 | 274 | 99.2% | 96.4% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,818 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | John Hancock |
|---|---|---|---|---|---|---|
| 10X GENOMICS, INC. | June 4, 2026 | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended 1982 Restricted Stock Award Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 6 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended Strategic Deployment Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 6 funds |
| 4D MOLECULAR THERAPEUTICS, INC. | June 17, 2026 | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers (''say-on-pay vote''). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| AAR CORP. | September 16, 2025 | Advisory proposal to approve our Fiscal Year 2025 executive compensation Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000. Compensation |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Approval of 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| ACCENDRA HEALTH, INC. | May 14, 2026 | Non-Binding advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| ACCENTURE PLC | January 28, 2026 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 16 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | AGAINST 7 funds |
FOR 4 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval, by non-binding advisory vote, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 5 funds |
| ACME UNITED CORPORATION | April 27, 2026 | Approval, by non-binding advisory vote, of the compensation of the named executive officers of the Company as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| ADAPTHEALTH CORP. | June 18, 2026 | Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 6 funds |
| ADESSO SE | June 3, 2026 | APPROVE REMUNERATION POLICY Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| AEBI SCHMIDT HOLDING AG | May 21, 2026 | Election of Barend Fruithof as the Chair of the Board of Directors Corporate Governance |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| AEHR TEST SYSTEMS | October 20, 2025 | Proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AEROVIRONMENT, INC. | September 25, 2025 | Management proposal to approve the amendment and restatement of the company's 2021 equity incentive plan Compensation |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AES CORP | April 29, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 10 funds |
| AFFIRM HOLDINGS, INC. | December 15, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 4 funds |
| AGILYSYS, INC. | September 4, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers set forth in the attached Proxy Statement Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To vote, on an advisory basis, to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| AIR LEASE CORPORATION | December 18, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of Air Lease Corporation in connection with the merger (the ''Compensation Proposal''). Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 7 funds |
| AKTIA BANK PLC | April 1, 2026 | REELECT JOAKIM FRIMODIG (VICE CHAIR), JUHA HAMMAREN (CHAIR), MARIA JERHAMRE ENGSTROM, HANNE KATRAMA, HARRI LAUSLAHTI AND SARI SOMERKALLIO AS DIRECTORS; ELECT ELINA FOGELHOLM AS NEW DIRECTOR Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ALARM.COM HOLDINGS, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 5 funds |
| ALEXANDER & BALDWIN, INC. | March 9, 2026 | To consider and vote on a proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 13 funds |
| ALK-ABELLO A/S | March 16, 2026 | REELECT ALAN MAIN AS DIRECTOR Director Elections |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
| ALK-ABELLO A/S | March 16, 2026 | REELECT ANDERS HEDEGAARD (CHAIR) AS DIRECTOR Director Elections |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
| ALK-ABELLO A/S | March 16, 2026 | REELECT LENE SKOLE (VICE CHAIR) AS DIRECTOR Director Elections |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| ALLY FINANCIAL INC. | May 6, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 8 funds |
| ALPHA & OMEGA SEMICONDUCTOR LTD | November 12, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as described in the Proxy Statement Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| ALPHATEC HOLDINGS, INC. | June 10, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| ALTUS GROUP LTD | May 6, 2026 | ELECT DIRECTOR COLIN J. DYER Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| AMADEUS FIRE AG | May 28, 2026 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Vote on Proposal to Approve the Company's Amended and Restated 2011 Stock Plan for Non-Employee Directors Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| AMENTUM HOLDINGS, INC | February 6, 2026 | Advisory vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| AMERICA'S CAR-MART, INC. | September 25, 2025 | To approve an advisory resolution regarding the Company's compensation of its named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| AMERICAN AIRLINES GROUP INC. | June 10, 2026 | A proposal to approve the Amended and Restated 2023 Incentive Award Plan Compensation |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | To approve the 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| AMERICAN SUPERCONDUCTOR CORPORATION | July 25, 2025 | To approve, on an advisory basis, the compensation of AMSC's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AMERICAN TOWER CORPORATION | May 20, 2026 | To approve the American Tower Corporation 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| AMERICAN WOODMARK CORPORATION | August 21, 2025 | To approve on an advisory basis the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| AMERIGO RESOURCES LTD | April 27, 2026 | ELECT DIRECTOR MARGOT NAUDIE Director Elections |
Board | Not determined | WITHHOLD 6 funds |
ABSTAIN 1 fund |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AMPER SA | June 29, 2026 | REELECT FERNANDO CASTRESANA MORENO AS DIRECTOR Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| AMPER SA | June 29, 2026 | REELECT JOSE FERNANDEZ GONZALEZ AS DIRECTOR Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| AMPLITUDE, INC. | June 9, 2026 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| AMRIZE AG | April 21, 2026 | Re-election of Jan Jenisch as Chairman of the Board Corporate Governance |
Board | For | FOR 13 funds |
AGAINST 2 funds |
| AMS-OSRAM AG | June 10, 2026 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ANGIODYNAMICS, INC. | November 10, 2025 | Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 3 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 5 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 4 funds |
| ANNEXON, INC. | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 12 funds |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 11 funds |
| APOGEE ENTERPRISES, INC. | June 24, 2026 | APPROVAL OF THE APOGEE ENTERPRISES, INC. 2019 STOCK INCENTIVE PLAN, AS AMENDED AND RESTATED (2026) TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR AWARDS FROM 2,150,000 TO 2,950,000. Compensation |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| APPEN LTD | May 22, 2026 | APPROVE REMUNERATION REPORT Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| APPFOLIO, INC. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve the 2026 equity incentive plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| AQUESTIVE THERAPEUTICS, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | FOR 10 funds |
AGAINST 4 funds |
| ARCTURUS THERAPEUTICS, HOLDINGS INC. | June 5, 2026 | Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| ARDELYX, INC | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| ARLO TECHNOLOGIES, INC. | June 18, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| ARMOUR RESIDENTIAL REIT, INC. | April 30, 2026 | To approve ARMOUR's Fourth Amended and Restated 2009 Stock Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| ARNOLDO MONDADORI EDITORE SPA | April 21, 2026 | APPROVE SECOND SECTION OF THE REMUNERATION REPORT Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ARQ, INC. | June 10, 2026 | To approve the Arq, Inc. 2026 Omnibus Incentive Plan; and Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| ARRAY TECHNOLOGIES, INC. | May 19, 2026 | Approval, on an advisory basis, of our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 7 funds |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| ARVINAS, INC. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| ASHTROM GROUP LTD | July 24, 2025 | REELECT AVRAHAM NUSSBAUM AS DIRECTOR Director Elections |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ASSEMBLY BIOSCIENCES, INC. | June 4, 2026 | Approval of an amendment to our Amended and Restated 2018 Stock Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,200,000 shares. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ASTRIA THERAPEUTICS, INC. | January 21, 2026 | To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled ''Golden Parachute Compensation'' and its accompanying footnotes which is included in the section of the proxy statement entitled ''The Merger-Interests of Astia's Directors and Executive Officers in the Merger,'' as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| ASTRONICS CORPORATION | May 28, 2026 | To approve the adoption of the Astronics Corporation 2026 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 13 funds |
FOR 3 funds |
| ATEA PHARMACEUTICALS, INC. | June 18, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| ATHABASCA OIL CORP | May 7, 2026 | ELECT DIRECTOR JOHN FESTIVAL Director Elections |
Board | For | FOR 5 funds |
ABSTAIN 2 funds |
| ATLAS ENERGY SOLUTIONS INC. | May 7, 2026 | Please indicate your vote, on a non-binding advisory basis, on the Company's Named Executive Officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| AVADEL PHARMACEUTICALS PLC | January 12, 2026 | Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| AVANOS MEDICAL,INC. | April 21, 2026 | Approval of an amendment to the Company's 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company's outside directors. Compensation |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| AVEPOINT, INC. | May 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 6 funds |
| AVIAT NETWORKS, INC. | November 5, 2025 | Advisory, non-binding vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| AVIAT NETWORKS, INC. | November 5, 2025 | Approval of Third Amended and Restated 2018 Incentive Plan of the Company. Compensation |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| AVIDXCHANGE HOLDINGS, INC. | September 16, 2025 | To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| AVNET, INC. | November 21, 2025 | Advisory vote on named executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| AVNET, INC. | November 21, 2025 | Approval of the 2025 Stock Compensation and Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| AXACTOR ASA | May 6, 2026 | REELECT TERJE MJOS (CHAIR) AS DIRECTOR Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AXOGEN, INC. | June 23, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
Page 1 of 19 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.